The Autonomic Pattern

Valsa Madhava, MD

Oct 10

5 min read

Updated: 7 days ago

Week 4 of the Symptom Patterns Series

When the body’s internal-regulation symptoms dominate — and why they still deserve appropriate evaluation.

Recognizing the Autonomic Pattern

During benzodiazepine withdrawal, some people go through periods dominated by symptoms of internal-body regulation. The heart may race or pound, the body may sweat or swing between feeling too hot and too cold, there may be light-headedness, and the digestive system may become unsettled.

In this pattern, autonomic or internal-regulation symptoms are prominent. They may include changes in heart rate or palpitations, sweating, hot or cold sensations and temperature changes, light-headedness, and digestive changes such as nausea, cramping, or altered bowel habit. Companion symptoms may include anxiety or arousal, muscle tension, and sleep disruption.

No single symptom identifies the pattern, and the same symptom may occur in other patterns.

A note on two of these symptoms: digestive symptoms sit at an overlap. The gut has its own regulation, influenced by but not identical to the autonomic nervous system, so these symptoms are best thought of as autonomic–visceral rather than purely autonomic. And the pattern itself is a way of grouping symptoms that may appear together. It is not a diagnosis of “dysautonomia” and does not establish that the autonomic nervous system is malfunctioning.

Two illustrative pictures:

Waves of palpitations, nausea, and sweating that come and go.
Light-headedness with digestive upset and feeling alternately too hot or too cold.

These examples illustrate the clinical picture. They do not establish whether the cause is withdrawal, anxiety, a medical condition, or a combination. New, severe, or unexpected symptoms deserve prompt medical evaluation.

Why These Symptoms Need Care in Interpretation

Autonomic symptoms are real, but they are also strongly nonspecific. A racing heart, nausea, sweating, or dizziness can arise with anxiety, and they can arise from a range of medical conditions that have nothing to do with benzodiazepines.

Because of that overlap, these symptoms should not be assumed to be “just withdrawal.” The same experience that can occur during withdrawal can also be the body signaling something that needs attention.

So interpretation has to hold two things at once: these symptoms genuinely occur in withdrawal, and they are not specific enough to identify their own cause.

When Symptoms Deserve Medical Evaluation

This leads to a simple, important point: new, severe, or unexpected symptoms deserve prompt medical evaluation, regardless of whether withdrawal is also present.

Seeking evaluation is not a failure to cope with withdrawal, and it is not at odds with recognizing a pattern. Appropriate medical assessment is part of understanding what is happening. It is how other causes are considered and, where needed, addressed.

Recognizing the Autonomic Pattern is useful precisely because it sits alongside good medical care, not instead of it.

Information That May Add Context

No single piece of information settles what a symptom means, but some can add context:

the relationship of symptoms to a dose reduction or cessation;
whether appropriate medical evaluation has already considered other causes;
how the present symptoms compare with what the person experienced before benzodiazepine use;
how symptoms evolve over time.

None of these features proves the cause on its own, and none replaces medical evaluation of new or concerning symptoms.

What the Pattern Can — and Cannot — Tell Us

Recognizing the Autonomic Pattern can make a confusing, body-wide experience feel more coherent, and it can help a person and their clinician describe and follow what is happening.

Within the Five-Axis Stress Biology Framework™ educational framework, this picture is interpreted as one in which symptoms linked to Autonomic Regulation (Axis 3) are especially prominent.

Because autonomic regulation is involved in internal-body functions and is closely linked with threat and arousal circuitry, it is biologically plausible that autonomic processes may contribute to some of these symptoms. But human benzodiazepine-withdrawal studies have not demonstrated that mechanism in this pattern. The interpretation is a way of organizing the experience, not a measured finding in an individual.

It is also worth being clear about what supports this pattern as a category. The Autonomic Pattern is a descriptive grouping of symptoms that may appear together. It is not a statistically established subtype, and it is not a diagnosis of autonomic dysfunction.

So recognition is useful, but it is not a diagnosis and does not establish a mechanism. It does not, by itself, tell a person whether their symptoms are withdrawal, anxiety, a medical condition, or a combination. Severe autonomic experiences are not universal in withdrawal.

These questions are worth working through with a clinician, and no medication should be changed on the basis of a symptom picture alone.

Transition to the Motor Pattern

Alongside these internal-regulation symptoms, some people notice tremor, twitching, muscle tension, and restlessness — symptoms of movement and muscle control rather than internal-organ regulation.

The next article describes the Motor Pattern, in which those symptoms become the dominant part of the picture.

Figure 4. The Autonomic Pattern

This figure illustrates a symptom picture in which internal-regulation symptoms are especially prominent. Symptoms inside the outline are examples of core autonomic or autonomic–visceral symptoms. Symptoms outside the outline are companion symptoms that may appear alongside them or overlap with other patterns. The figure is descriptive: it does not diagnose dysautonomia, show that all symptoms have one cause, or replace medical evaluation. Autonomic symptoms are nonspecific, and new, severe, or unexpected symptoms deserve prompt medical evaluation.

About the Evidence

These patterns are provisional educational descriptions informed by published withdrawal literature, the Five-Axis Stress Biology Framework™ educational framework, clinical observation, and the author’s own exploratory analysis, which is in preparation for publication and has not yet been externally replicated.

They are not diagnoses or fixed subtypes and do not establish a mechanism. Autonomic symptoms are not specific to withdrawal — they also occur with anxiety and with a range of medical conditions — so new, severe, or unexpected symptoms deserve prompt medical evaluation.

These descriptions do not replace individual medical evaluation, and medication changes should not be made on the basis of them alone.

Selected Scientific References

Ashton, H. (1991). Protracted withdrawal syndromes from benzodiazepines. Journal of Substance Abuse Treatment, 8(1–2), 19–28. https://doi.org/10.1016/0740-5472(91)90023-4
Shade, K. N., et al. (2025). Long-term neurological consequences following benzodiazepine exposure: A scoping review. PLOS ONE, 20(8), e0330277. https://doi.org/10.1371/journal.pone.0330277
Lu, D., Uldry Lavergne, C. G., Choi, S., Park, J., Kim, J., Zhao, S., Desimone, Q., Lendaro, E., Chen, B., Han, B.-X., Wang, F., & Goldstein, N. (2024). General anesthesia activates a central anxiolytic center in the BNST. Cell Reports, 43(11), 114909. https://doi.org/10.1016/j.celrep.2024.114909
Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration in emotion regulation and dysregulation. Journal of Affective Disorders, 61(3), 201–216. https://doi.org/10.1016/S0165-0327(00)00338-4
Thayer, J. F., & Lane, R. D. (2009). Claude Bernard and the heart–brain connection: Further elaboration of a model of neurovisceral integration. Neuroscience & Biobehavioral Reviews, 33(2), 81–88. https://doi.org/10.1016/j.neubiorev.2008.08.004

The neurovisceral-integration references describe brain–autonomic links in general and are cited only for broad biological plausibility; they were not conducted in benzodiazepine withdrawal and do not explain this pattern. The BNST study is cited as preclinical circuit-level plausibility for links among diazepam-responsive/anxiolytic circuitry, anxiety-like behavior, heart rate, and heart-rate variability; it was conducted in mice and did not study chronic benzodiazepine exposure, withdrawal, or dysautonomia. These references are cited as plausibility, not as mechanisms demonstrated in human benzodiazepine withdrawal. The Series 4 organizational analysis is the author’s own exploratory analysis, in preparation for publication and not yet externally replicated.

For educational purposes only. Not a substitute for individual medical evaluation.